Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection.
Open Access
- 1 June 1989
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 169 (6) , 2021-2027
- https://doi.org/10.1084/jem.169.6.2021
Abstract
Tumor necrosis factor/cachectin (TNF/C) is the principal mediator of bacterial endotoxin-induced shock and death. We found that the C3H/HeJ mouse, which is less able to produce TNF/C in response to endotoxin, has a 1,000-fold greater susceptibility to lethal infection with Escherichia coli than the TNF-responsive congenic mouse, C3H/HeN. This surprising finding suggested that this lethal peptide may also be involved in host protection. To test this hypothesis we pretreated the C3H/HeJ mouse with a combination of recombinant murine TNF/C-alpha and IL-1 alpha. This combination protected these mice against an intraperitoneal bacterial challenge of greater than 20 LD50S (nearly 2 x 10(2) CFU) that grew to a level of greater than 10(7) CFU/ml of blood and per gram of liver in untreated mice. This suggests a significant role for these cytokines in host defenses against invasive infections that require bacterial replication within the host. These protective mechanisms may not be important for less virulent organisms. These findings may have important implications for the proposed use of anti-TNF/C agents in the treatment of septic shock.This publication has 31 references indexed in Scilit:
- CYTOKINE APPEARANCE IN HUMAN ENDOTOXEMIA AND PRIMATE BACTEREMIA1988
- Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro.The Journal of Immunology, 1987
- Tumor Necrosis Factor (Cachectin) as an Essential Mediator in Murine Cerebral MalariaScience, 1987
- Tumor Necrosis Factor and Interleukin 1 as Mediators of Endotoxin-Induced Beneficial EffectsClinical Infectious Diseases, 1987
- Recombinant tumor necrosis factor/cachectin and interleukin 1 pretreatment decreases lung oxidized glutathione accumulation, lung injury, and mortality in rats exposed to hyperoxia.Journal of Clinical Investigation, 1987
- Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes.Journal of Clinical Investigation, 1987
- Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors.The Journal of Immunology, 1985
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Human granulocyte-macrophage colony-stimulating factor is a neutrophil activatorNature, 1985
- The Importance of the K1 Capsule in Invasive Infections Caused by Escherichia coliThe Journal of Infectious Diseases, 1984